Bevacizumab-based triplet versus doublet chemotherapy as first-line treatment for metastatic right-sided colon cancer: Results of the KCSG CO19-18 phase II trial.

  • Kim, Jee Hung
  • Kim, Hyunwook
  • Lee, Myung Ah
  • Hwang, In Gyu
  • Sym, Sun Jin
  • 외 8명
Citations

WEB OF SCIENCE

0
제목
Bevacizumab-based triplet versus doublet chemotherapy as first-line treatment for metastatic right-sided colon cancer: Results of the KCSG CO19-18 phase II trial.
저자
Kim, Jee HungKim, HyunwookLee, Myung AhHwang, In GyuSym, Sun JinAn, Ho JungKim, Tae WonNam, Eun MiKang, Seok YunBeom, Seung-HoonKim, Han SangShin, Sang JoonAhn, Joong Bae
DOI
10.1200/JCO.2026.44.16_suppl.e15562
발행일
2026-06
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
44
16_SUPPL